BioSpace News Archive

Myovant Sciences, a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy, announced that it approved equity awards for 11 new employees with a grant date of August 15, 2022 pursuant to Myovant’s 2020 Inducement Plan.

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, announced today a multi-year, strategic, collaboration agreement between ICL and Lavie Bio Ltd., a subsidiary of Evogene.

NeoGenomics, Inc. today announced, as required by the Nasdaq Listing Rules, equity inducement awards to Mr. Chris Smith, the company’s new chief executive officer.